FAM Funds
Fenimore Private Client Group
Investment Advisors
About Fenimore

Investment Advisors


Stock Update: Stryker Corp.

Stryker was the best performing company, on a dollar-weighted basis, in the Fund for 2016 with a gain of $2.58 million. Stryker is a leader in orthopedic implants, such as hips and knees, as well as medical and surgical products like hospital beds and surgical instruments. Management continued to produce adjusted earnings growth in the low- to mid-teens for the year. One of the hallmarks of Stryker is their top-notch management team and solid execution. The corporation has been able to consistently grow their market share by bringing innovative products to the market and providing attractive and economic solutions to healthcare providers. Stryker also has a history of making accretive acquisitions which add to sales and earnings growth. In 2016, they bought Physio-Control, which is a leader in the Automated External Defibrillator (AED) market. This is a mature market, but there is a replacement cycle that should drive future growth. Another avenue of growth should come from international expansion as Stryker has less penetration in this market than its peers. We do not believe changes in the Affordable Care Act will have a material impact on the business in the future.  

The portfolio is actively managed. For the FAM Equity-Income Fund's current Top 10 Holdings to the most recent quarter-end, view its Portfolio Details.

To obtain the FAM Equity-Income Fund's performance data that is current to the most recent month-end, click here.

More Updates:

800.932.3271 / 384 North Grand Street, Cobleskill, NY 12043
Copyright © 2017 FAM Funds | Privacy Policy | Terms of Use | Sitemap